GLP-1 drugs: what Wyoming Medicaid paid

Wyoming Medicaid shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Wyoming Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Wyoming Medicaid’s payment record shows

In 2026Q1, the product Wyoming Medicaid paid for most often was Mounjaro®, at 401 prescriptions⁷ of the 1,113 to 1,185^{1,7,13,19,25,37} across all 8 products, or 36 percent of the published count.

Wyoming Medicaid itself reimbursed at least $1,160,546 for these products in the quarter, about $1,050 per prescription. Pharmacies were paid $1,166,091 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,176.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Wyoming Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Wyoming Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Wyoming Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Wyoming Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Fee-for-service	227¹	21%	$241,230	$241,230	$1,063
tirzepatideMounjaro®	Fee-for-service	401⁷	36%	$428,263	$428,263	$1,068
semaglutideWegovy®	Fee-for-service	at least 106¹³	10%	$124,687	$129,450	$1,176
semaglutideOzempic®	Fee-for-service	256¹⁹	23%	$259,163	$259,945	$1,012
semaglutideRybelsus®	Fee-for-service	68²⁵	6%	$72,653	$72,653	$1,068
liraglutideSaxenda®	Not published	No row	n/a	Not published	Not published	Not published
liraglutideVictoza®	Fee-for-service	47³⁷	4%	$34,550	$34,550	$735
liraglutideliraglutide (generic)	Fee-for-service	Withheld	n/a	Not published	Not published	Not published

Every published claim in this record came through fee-for-service, meaning the program paid the pharmacy directly. This record shows no managed-care claims for these products. That is a fact about how the file reports, and it points at who to ask: the program.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 47 against 150. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 20.1 to 21.4 prescriptions per thousand people enrolled in Wyoming Medicaid, on an average of 55,316 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 34 of the 168 product-quarters it holds a row for here, which is 20 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Across every quarter on file, the federal record holds no row at all for Saxenda®. That is an absence in the file rather than a refusal by Wyoming Medicaid: no prescription was reported, and the reason is not published here.

Ozempic® carries a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Wyoming Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Wyoming Medicaid paid for each product, quarter by quarter

Prescriptions Wyoming Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable²Withheld6 of 6 product codes withheld	at least 37 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$39,223 paid	at least 63 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$62,564 paid	at least 14 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$13,860 paid	227 paid prescriptions in the quarter (2026Q1)¹Count$241,230 paid
tirzepatideMounjaro®range 134 to 401	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable¹¹Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁰Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁰Withheld4 of 4 product codes withheld	at least 47 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$46,656 paid	at least 83 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$79,745 paid	at least 112 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$111,503 paid	187 paid prescriptions in the quarter (2024Q2)⁹Count$191,687 paid	134 paid prescriptions in the quarter (2024Q3)⁹Count$137,631 paid	149 paid prescriptions in the quarter (2024Q4)⁹Count$151,329 paid	at least 160 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$164,585 paid	198 paid prescriptions in the quarter (2025Q2)⁸Count$197,990 paid	204 paid prescriptions in the quarter (2025Q3)⁸Count$207,865 paid	at least 62 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$64,381 paid	401 paid prescriptions in the quarter (2026Q1)⁷Count$428,263 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter¹⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable¹⁵Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable¹⁵Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable¹⁴Withheld5 of 5 product codes withheld	at least 12 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$13,833 paid	at least 13 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$13,937 paid	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable¹⁴Withheld5 of 5 product codes withheld	at least 106 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$124,687 paid
semaglutideOzempic®range 32 to 294	at least 16 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$12,167 paid	at least 17 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$15,660 paid	at least 31 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$24,878 paid	32 paid prescriptions in the quarter (2021Q4)²⁴Count$22,386 paid	44 paid prescriptions in the quarter (2022Q1)²³Count$32,803 paid	at least 60 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$53,525 paid	at least 60 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$52,113 paid	at least 72 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$57,323 paid	at least 108 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$89,057 paid	at least 126 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$115,942 paid	115 paid prescriptions in the quarter (2023Q3)²²Count$103,369 paid	117 paid prescriptions in the quarter (2023Q4)²²Count$104,557 paid	146 paid prescriptions in the quarter (2024Q1)²¹Count$134,863 paid	294 paid prescriptions in the quarter (2024Q2)²¹Count$293,335 paid	at least 178 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$171,684 paid	157 paid prescriptions in the quarter (2024Q4)²¹Count$150,250 paid	156 paid prescriptions in the quarter (2025Q1)²⁰Count$150,075 paid	155 paid prescriptions in the quarter (2025Q2)²⁰Count$145,697 paid	156 paid prescriptions in the quarter (2025Q3)²⁰Count$146,412 paid	at least 48 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$46,080 paid	256 paid prescriptions in the quarter (2026Q1)¹⁹Count$259,163 paid
semaglutideRybelsus®	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁰Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable³⁰Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable³⁰Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁰Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable²⁹Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable²⁹Withheld2 of 2 product codes withheld	at least 11 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$9,505 paid	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable²⁹Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable²⁸Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable²⁸Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable²⁸Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable²⁸Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable²⁷Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable²⁷Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable²⁷Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable²⁷Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable²⁶Withheld2 of 2 product codes withheld	at least 18 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$17,545 paid	at least 35 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$34,161 paid	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable²⁶Withheld3 of 3 product codes withheld	68 paid prescriptions in the quarter (2026Q1)²⁵Count$72,653 paid
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 47 to 263	150 paid prescriptions in the quarter (2021Q1)⁴²Count$139,691 paid	163 paid prescriptions in the quarter (2021Q2)⁴²Count$150,733 paid	193 paid prescriptions in the quarter (2021Q3)⁴²Count$173,087 paid	207 paid prescriptions in the quarter (2021Q4)⁴²Count$185,283 paid	190 paid prescriptions in the quarter (2022Q1)⁴¹Count$183,834 paid	214 paid prescriptions in the quarter (2022Q2)⁴¹Count$204,047 paid	223 paid prescriptions in the quarter (2022Q3)⁴¹Count$208,881 paid	213 paid prescriptions in the quarter (2022Q4)⁴¹Count$205,679 paid	263 paid prescriptions in the quarter (2023Q1)⁴⁰Count$255,197 paid	255 paid prescriptions in the quarter (2023Q2)⁴⁰Count$255,402 paid	254 paid prescriptions in the quarter (2023Q3)⁴⁰Count$248,103 paid	230 paid prescriptions in the quarter (2023Q4)⁴⁰Count$228,121 paid	176 paid prescriptions in the quarter (2024Q1)³⁹Count$135,704 paid	137 paid prescriptions in the quarter (2024Q2)³⁹Count$106,555 paid	106 paid prescriptions in the quarter (2024Q3)³⁹Count$76,945 paid	69 paid prescriptions in the quarter (2024Q4)³⁹Count$50,315 paid	at least 24 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$13,894 paid	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	47 paid prescriptions in the quarter (2026Q1)³⁷Count$34,550 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable⁴⁵Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable⁴⁵Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable⁴⁴Withheld4 of 4 product codes withheld	at least 40 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$21,448 paid	at least 13 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$5,183 paid	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable⁴⁴Withheld6 of 6 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable⁴³Withheld7 of 7 product codes withheld

What this page cannot tell you

Whether Wyoming Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Wyoming in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, WY
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state WY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "63"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, WY
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state WY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "33"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, WY
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state WY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like ZEPBOUND%, state WY, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, WY
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state WY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like ZEPBOUND%, state WY, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, WY
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state WY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like ZEPBOUND%, state WY, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, WY
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state WY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like ZEPBOUND%, state WY, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, WY
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state WY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO 7", "suppression_used": "false", "number_of_prescriptions": "79"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, WY
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state WY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "56"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, WY
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state WY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2024", "quarter": "2", "utilization_type": "FFSU", "product_name": "MOUNJARO 2", "suppression_used": "false", "number_of_prescriptions": "58"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, WY
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state WY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "28"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, WY
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state WY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 1", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, WY
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state WY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like MOUNJARO%, state WY, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, WY
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state WY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "31"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, WY
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state WY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "13"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, WY
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state WY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 0.5", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, WY
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state WY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like WEGOVY%, state WY, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, WY
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state WY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like WEGOVY%, state WY, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, WY
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state WY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like WEGOVY%, state WY, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, WY
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state WY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "129"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, WY
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state WY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "72"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, WY
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state WY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2024", "quarter": "2", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "150"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, WY
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state WY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "63"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, WY
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state WY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "42"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, WY
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state WY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2021", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "19"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, WY
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state WY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 3", "suppression_used": "false", "number_of_prescriptions": "24"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, WY
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state WY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 3", "suppression_used": "false", "number_of_prescriptions": "18"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, WY
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state WY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 3", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, WY
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state WY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 3", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, WY
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state WY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "11"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, WY
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state WY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 3", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, WY
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state WY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like SAXENDA%, state WY, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, WY
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state WY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like SAXENDA%, state WY, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, WY
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state WY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like SAXENDA%, state WY, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, WY
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state WY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like SAXENDA%, state WY, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, WY
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state WY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like SAXENDA%, state WY, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, WY
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state WY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like SAXENDA%, state WY, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, WY
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state WY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "29"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, WY
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state WY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "24"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, WY
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state WY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "105"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, WY
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state WY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "153"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, WY
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state WY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "126"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, WY
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state WY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "115"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, WY
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state WY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "WY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, WY
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state WY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "14"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, WY
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state WY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, WY
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state WY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like LIRAGLUTID%, state WY, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, WY
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state WY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like LIRAGLUTID%, state WY, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, WY
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state WY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "WY", "product_name": "product_name like LIRAGLUTID%, state WY, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 31 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 17 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Wyoming Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.